Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates

(2012) Merry R. Sherman et al.   BIOCONJUGATE CHEMISTRY

Therapeutic perspectives on uricases for gout

(2012) Ricardo P. Garay et al.   JOINT BONE SPINE

Enhanced gene delivery using Bubble liposomes and ultrasound for folate-PEG liposomes

(2012) Daiki Omata et al.   JOURNAL OF DRUG TARGETING

Strategies for extended serum half-life of protein therapeutics

(2011) Roland E Kontermann   CURRENT OPINION IN BIOTECHNOLOGY

Modulating antibody pharmacokinetics using hydrophilic polymers

(2011) Chen Chen et al.   Expert Opinion on Drug Delivery

Pegloticase and Chronic Gout--Reply

(2011) J. S. Sundy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON

(2010) H. Tillmann et al.   JOURNAL OF HEPATOLOGY

Product development issues for PEGylated proteins

(2010) Robert W. Payne et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose

(2010) Nathan C. Geething et al.   PLoS One

Emerging PEGylated drugs

(2009) Jung Seok Kang et al.   EXPERT OPINION ON EMERGING DRUGS

Characterization, stabilization and activity of uricase loaded in lipid vesicles

(2009) Q.Y. Tan et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Biochemical and biopharmaceutical properties of PEGylated uricase

(2009) Débora da Silva Freitas et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process

(2008) I. Hamad et al.   MOLECULAR IMMUNOLOGY

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

(2007) Merry R. Sherman et al.   ADVANCED DRUG DELIVERY REVIEWS